<ѻýҕl>Many With Cancer Predisposition Diseases Unaware of Genetic Statusѻýҕl> Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
<ѻýҕl>Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrenceѻýҕl> Chemotherapy regimens with higher cumulative dose provide greatest benefit Apr 14, 2023
<ѻýҕl>Local Anesthesia Before Breast Cancer Surgery Improves OS in Randomized Trialѻýҕl> Intervention is inexpensive, easy to implement, researchers say Apr 07, 2023
<ѻýҕl>High Out-of-Pocket Costs Tied to Less Follow-Up After Initial Mammographyѻýҕl> Plans dominated by copays and deductibles are associated with higher out-of-pocket costs Mar 27, 2023
<ѻýҕl>Progestin-Only Birth Control Linked to Small Increase in Breast Cancer Riskѻýҕl> But risk is similar to combined hormonal contraceptive use Mar 22, 2023
<ѻýҕl>Focus on Optimizing Use of CDK4/6 Inhibitors in Metastatic HR+ Breast Cancerѻýҕl> Choice of agent, post-progression treatment, and resistance mechanisms top unanswered questions Mar 08, 2023
<ѻýҕl>Understanding of HER2-Low Breast Cancer Continues to Evolveѻýҕl> New breast cancer subtype proves challenging to define molecularly, pathologically, clinically Mar 07, 2023
<ѻýҕl>Cases of Breast Implant-Associated Lymphoma Continue to Accumulateѻýҕl> More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
<ѻýҕl>'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancerѻýҕl> Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
<ѻýҕl>Antibody-Drug Conjugates Take Breast Cancer Field by Stormѻýҕl> Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
<ѻýҕl>These Surgeries Made the Sharpest Turns to Outpatient Setting After COVIDѻýҕl> Several procedures saw significant increases in outpatient volumes Mar 03, 2023
<ѻýҕl>How to Make Meaningful Moves Toward Health Equity in Cancer Careѻýҕl> Addressing the three R's: resources, research, and racism Feb 27, 2023
<ѻýҕl>Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patientsѻýҕl> Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
<ѻýҕl>FDA Greenlights First Drug for ESR1-Mutated Breast Cancerѻýҕl> Elacestrant almost doubled PFS versus standard endocrine therapy in advanced ER+/HER2- disease Jan 30, 2023
<ѻýҕl>MRI-Guided Focused Ultrasound Eases Pain From Bone Metastasesѻýҕl> More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
<ѻýҕl>Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgeryѻýҕl> Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
<ѻýҕl>Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancerѻýҕl> Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
<ѻýҕl>Mixed Results With Hormonal Strategies for Premenopausal Breast Cancerѻýҕl> Exemestane reduced recurrence, metastasis versus tamoxifen, but no survival benefit Dec 20, 2022
<ѻýҕl>Less Is More Wins Again: Avoiding Node Dissection in Early Breast Cancerѻýҕl> First comparison of targeted sentinel node assessment shows no difference in recurrence rates Dec 09, 2022
<ѻýҕl>Adding AKT Inhibitor Doubles PFS in Advanced, HR-Positive Breast Cancerѻýҕl> In phase III trial, capivasertib benefited patients with or without AKT pathway alterations Dec 09, 2022
<ѻýҕl>Oral SERD Tops Fulvestrant for PFS in ER-Positive Breast Cancerѻýҕl> Camizestrant also led to meaningful PFS improvements in those with detectable ESR1 mutations Dec 09, 2022
<ѻýҕl>Continuing CDK4/6 Inhibitor Beyond Progression No Help in Metastatic Breast Cancerѻýҕl> Prior therapy, baseline mutations confound results; "intriguing" benefit with PD-L1 inhibitor Dec 09, 2022
<ѻýҕl>Pausing Endocrine Therapy for Pregnancy Safe in Early Breast Cancerѻýҕl> Study suggests no increased risk of cancer recurrence versus historical control Dec 09, 2022
<ѻýҕl>T-DXd Continues Winning Streak in Metastatic, HER2-Positive Breast Cancerѻýҕl> Trastuzumab deruxtecan improves survival in second- and later-line settings Dec 08, 2022
<ѻýҕl>Neoadjuvant T-DXd Active in HER2-Low Breast Cancerѻýҕl> Response rates on the order of 58-68%, with or without endocrine therapy Dec 08, 2022
<ѻýҕl>Everolimus Fails Again as Adjuvant Therapy for High-Risk Breast Cancerѻýҕl> No improvement in the overall analysis but a hint of benefit in premenopausal patients Dec 08, 2022
<ѻýҕl>Assay Predicts Breast Cancer Patients Who Will Benefit From Ovarian Suppressionѻýҕl> Low score suggests improved outcomes with ovarian suppression plus adjuvant endocrine therapy Dec 07, 2022
<ѻýҕl>First-Line CDK4/6 Thumps Chemo in Aggressive, Advanced Breast Cancerѻýҕl> Doubling of PFS could be death knell for combination chemotherapy in difficult-to-treat subgroup Dec 07, 2022
<ѻýҕl>Metastasis 'Doorway' May Lead to Racial Disparities in Breast Cancerѻýҕl> Density of cellular complex after neoadjuvant therapy tied to cancer subtypes, may be targetable Dec 07, 2022
<ѻýҕl>Exercise During Chemo Shows Benefits for Cardiorespiratory Fitnessѻýҕl> However, patients who exercise after chemo also ultimately see benefits too Nov 21, 2022
<ѻýҕl>RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Laterѻýҕl> But "that's not the intent of radiation therapy," says outside expert Nov 18, 2022
<ѻýҕl>Oral, Hormone-Free Med Reduces Hot Flashes in Breast Cancer Patientsѻýҕl> Q-122 was effective, well-tolerated in those on oral adjuvant endocrine therapy Nov 11, 2022
<ѻýҕl>My Risk Revealed: A Confirmed BRCA2 Mutationѻýҕl> My dad's cancer diagnosis offered me invaluable information Oct 30, 2022
<ѻýҕl>Study Suggests Potential to Skip Surgery for Selected Breast Cancer Patientsѻýҕl> No recurrences in 2 years after pathologic complete response in TNBC, HER2-positive tumors Oct 26, 2022
<ѻýҕl>Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancerѻýҕl> Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
<ѻýҕl>Nerve-Freezing Technique Staves Off Post-Mastectomy Painѻýҕl> Percutaneous cryoneurolysis improved analgesia in a pilot study Oct 24, 2022
<ѻýҕl>Mepitel Film Beats Standard for Stopping Radiation Dermatitis in Breast Cancerѻýҕl> "The most improvement in skin toxicity that I have seen in many years," expert says Oct 19, 2022
<ѻýҕl>Risk of Secondary Breast Cancer After Childhood Cancer Is Declining, Study Suggestsѻýҕl> Improvement credited to changes in chest RT, attenuated by use of pelvic RT, anthracyclines Oct 13, 2022
<ѻýҕl>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancerѻýҕl> Risk is low but appears to have modifiable components Oct 13, 2022
<ѻýҕl>Katie Couric's Breast Cancerѻýҕl> The popular media personality is on a mission to raise awareness around dense breasts Oct 06, 2022